Kudo Biotechnology
PrivateCompany Overview
Kudo Biotechnology operates in Healthcare & Life Sciences and is based in Needham, Massachusetts. It was founded in 2023.
Kudo Biotechnology is a biotechnology company that provides end-to-end mRNA contract development and manufacturing organization (CDMO) services, including plasmid DNA, mRNA, and lipid nanoparticle (LNP) production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kudo Biotechnology Comparables
Compare Kudo Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vernal Biosciences | 92% | |
| Arcturus Therapeutics Holdings Inc. | 74% | |
| Merck | 74% |
For institutional investors. Book with your work email.
Kudo Biotechnology Funding Rounds
Historical fundraising activity
Kudo Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kudo Biotechnology's valuation, stock price, and market status.
Is Kudo Biotechnology a public or private company?
Kudo Biotechnology is a private company.
What is the current stock price of Kudo Biotechnology?
Kudo Biotechnology is a private company, so its shares have no public market price. Caplight tracks Kudo Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kudo Biotechnology worth (valuation)?
Valuation information for Kudo Biotechnology is not publicly available.
Can I buy Kudo Biotechnology stock?
Kudo Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kudo Biotechnology's last funding round?
Funding round information for Kudo Biotechnology is not publicly available.
Who are the main investors in Kudo Biotechnology?
Investor information for Kudo Biotechnology is not publicly disclosed.
Will Kudo Biotechnology IPO soon?
No public IPO plans have been announced for Kudo Biotechnology.
How can I track Kudo Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Kudo Biotechnology's shares on secondary markets.